Soluble Fas ligand levels in cerebrospinal fluid in neuro-Behçet's disease.
Aoyama-Hayashi
E
E
Department of Internal Medicine, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
Matsuda
T
T
Ohya
N
N
Tanaka
C
C
Kongozi
M
M
Kamo
C
C
Hotta
M
M
Ikejima
H
H
Shiraishi
M
M
Mizushima
Y
Y
D001172:Arthritis, Rheumatoid / Q000134:cerebrospinal fluid / Q000276:immunology; D001528:Behcet Syndrome / Q000134:cerebrospinal fluid* / Q000276:immunology / Q000503:physiopathology; D053222:Fas Ligand Protein; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000134:cerebrospinal fluid; D008562:Membrane Glycoproteins / Q000134:cerebrospinal fluid*; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid / Q000276:immunology; D009422:Nervous System Diseases / Q000134:cerebrospinal fluid* / Q000209:etiology / Q000276:immunology; D016463:Sweet Syndrome / Q000134:cerebrospinal fluid / Q000276:immunology
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins